Aberdeen discloses 7.49% InspireMD (NSPR) stake held for clients

Rhea-AI Filing Summary

Aberdeen Group plc and abrdn Inc. report a significant institutional holding in InspireMD, Inc. They beneficially own 3,173,364 shares of InspireMD common stock, representing 7.49% of the class. All voting and dispositive power over these shares is shared, with no sole voting or dispositive authority.

The firms state the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of InspireMD. abrdn Inc. holds the position on behalf of underlying clients that own 5% or more of this security class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 10:35 AM Learn about SEC filing dates

FAQ

What stake in InspireMD (NSPR) does Aberdeen Group and abrdn Inc. report?

Aberdeen Group plc and abrdn Inc. report beneficial ownership of 3,173,364 InspireMD common shares, representing 7.49% of the outstanding class. This makes them significant institutional holders of InspireMD, Inc. under U.S. reporting rules for large shareholdings.

Who are the reporting persons in this InspireMD (NSPR) Schedule 13G/A?

The filing identifies Aberdeen Group plc and abrdn Inc. as reporting persons. Aberdeen Group plc is the parent company, and abrdn Inc. is the entity that beneficially owns the shares on behalf of underlying clients in this InspireMD common stock position.

How much voting and dispositive power do Aberdeen and abrdn have over InspireMD (NSPR) shares?

The filing shows shared voting power over 3,173,364 shares and shared dispositive power over 3,173,364 shares, with zero sole voting or dispositive power. This indicates decisions are made on a shared basis for the reported InspireMD holdings.

Are Aberdeen and abrdn seeking control of InspireMD (NSPR) with this stake?

The certification states the securities were acquired and are held in the ordinary course of business and not for changing or influencing the control of InspireMD. The holdings are associated with normal investment activities rather than a control-seeking strategy.

On whose behalf does abrdn Inc. hold the InspireMD (NSPR) shares?

The exhibit explains that abrdn Inc. beneficially owns the shares on behalf of underlying clients. Those clients collectively hold 5% or greater of the outstanding shares of this InspireMD common stock class, making the position reportable under beneficial ownership rules.

What type of filing is this for InspireMD (NSPR) and what does it indicate?

This is an amended Schedule 13G, a beneficial ownership report used mainly by institutional investors holding large positions passively. It indicates Aberdeen Group plc and abrdn Inc. have a sizable but non-control-seeking stake in InspireMD common stock.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

InspireMD, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

45779A846

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 45779A846

1

Names of Reporting Persons

Aberdeen Group plc

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,173,364.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,173,364.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,173,364.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.49 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 45779A846

1

Names of Reporting Persons

abrdn Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,173,364.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,173,364.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,173,364.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.49 %

12

Type of Reporting Person (See Instructions)

CO, IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: InspireMD, Inc.
(b)	Address of issuer's principal executive offices: 6303 Waterford District Drive, Suite 215, Miami, FLORIDA 33126
Item 2.
(a)	Name of person filing: Aberdeen Group plc abrdn Inc.
(b)	Address or principal business office or, if none, residence: Aberdeen Group plc 1 George Street Edinburgh, United Kingdom EH2 2LL abrdn Inc. 1900 Market Street Suite 200 Philadelphia PA19103
(c)	Citizenship: Aberdeen Group plc - UNITED KINGDOM abrdn Inc. - UNITED STATES
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP No.: 45779A846
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,173,364
(b)	Percent of class: 7.49 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Aberdeen Group plc - 0 abrdn Inc. - 0
	(ii) Shared power to vote or to direct the vote: Aberdeen Group plc - 3,173,364 abrdn Inc. - 3,173,364
	(iii) Sole power to dispose or to direct the disposition of: Aberdeen Group plc - 0 abrdn Inc. - 0
	(iv) Shared power to dispose or to direct the disposition of: Aberdeen Group plc - 3,173,364 abrdn Inc. - 3,173,364
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Aberdeen Group plc

Signature:	F.Osei
Name/Title:	Frederic Osei/Major Shareholding Reporting Analyst
Date:	12/31/2025

abrdn Inc.

Signature:	F.Osei
Name/Title:	Frederic Osei/Major Shareholding Reporting Analyst
Date:	12/31/2025

Exhibit Information

Aberdeen Group plc abrdn Holdings Limited abrdn Inc. Aberdeen Group plc is the parent company. abrdn Holdings Limited is the intermediate holding company for abrdn Inc. abrdn Inc. beneficially owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.